AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease
Clinical trial NCT02284906 · TERMINATED
Trial details
- NCT number
- NCT02284906
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-12
- Primary completion
- 2018-01-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.